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Introduction
Hypertrophic cardiomyopathy (HCM) is the most com-
mon genetic heart disease. Congestive symptoms of
heart failure, such as effort dyspnea, may occur in this
cardiovascular disorder. Myocardial fibrosis is a patholo-
gical feature of extracellular matrix remodeling, that
may promote alterations in myocardial ventricular func-
tion. Magnetic Resonance Imaging (MRI) is now used as
an non-invasive standard tool to detect focal myocardial
fibrosis. The presence of scar using Delayed Enhance-
ment technique (DE) is related to a worse prognosis in
HCM. The relationship between the progression of
myocardial fibrosis and the functional clinical status was
not previously investigated.
Purpose
a) to assess the severity and speed of progression of left
ventricle (LV) fibrotic tissue formation by DE MRI b) to
investigate if a relation between the rate of progression
of LV scar and a worst clinical status exists.
Methods
In 29 patients with HCM (20 males; mean age 42 ±
19 years) we repeated two cardiac magnetic resonance
examinations, using a 1.5 Tesla scanner (GE Healthcare,
Milwaukee, USA). We evaluated LV mass and volumes
and LVEF by the acquisition of conventional SSFP cine
short axis images. DE was detected using T1 GRE IR
acquired 10 minutes following contrast injection. Quanti-
fication of DE was performed as previously described (1).
Results
At the first CMR DE was detected in 21 subjects (72%),
with an average extent of 8.1 ± 8 % of LV mass. CMR
was repeated after an average of 772 ± 300 days. At the
second CMR exam DE was found in 28 patients (97%).
Among them, 16 subjects showed a significant increase
of extent of DE (mean augment of 6.9 ± 5.5%, p< 0.0001).
During the time interval between the 2 examination,
NYHA class worsened in 10 patients who presented
higher increase of DE extent than those with preserved
functional status (8.3 ± 6.8 vs 3.4 ± 3.1, p < 0.04).
Conclusions
From these data we conclude that the progression of fibro-
sis in HCM is fast. The increase of extent of fibrosis in
these patients is related to a worse clinical status. Therefore
MRI can be applied as an useful safe tool, for longitudinal
follow up evaluation of progression of the disease.
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